Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Sadelain
    Sadelain
  3. Arcila
    Arcila
  4. Levine
    Levine
  5. O'Reilly
    O'Reilly
  6. Wolden
    Wolden
  7. Abdel-Wahab
    Abdel-Wahab
  8. Castro-Malaspina
    Castro-Malaspina
  9. Giralt
    Giralt
  10. Zelenetz
    Zelenetz

Groups

  1. Center for Hematologic Malignancies (257)
  2. Department of Medicine (214)
  3. Hematologic Malignancies, Division of (208)
  4. GSK Faculty (93)
  5. Adult Leukemia (67)
  6. Sloan Kettering Institute Faculty (63)
  7. Lymphoma (56)
  8. Executive Committee, Center for Hematologic Malignancies (52)
  9. Bone Marrow Transplant (51)
  10. Tow Center for Developmental Oncology (TCDO) (50)
Search Within
  1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (138)
  2. Meeting Abstract (99)
  3. Review (13)
  4. Correspondence (2)
  5. Editorial (2)
  6. Guidelines (2)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (257)
  2. Department of Medicine (214)
  3. Hematologic Malignancies, Division of (208)
  4. GSK Faculty (93)
  5. Adult Leukemia (67)
  6. Sloan Kettering Institute Faculty (63)

More Groups

People
  1. Steven Horwitz (18)
  2. Michel Sadelain (16)
  3. Maria Arcila (13)
  4. Richard O'Reilly (12)
  5. Ross Levine (12)
  6. Suzanne Wolden (12)

More People

Years
  1. 2025 (2)
  2. 2024 (16)
  3. 2023 (15)
  4. 2022 (11)
  5. 2021 (17)
  6. 2020 (26)

More Years

Publications
  1. Experimental Hematology (56)
  2. Lancet Oncology (34)
  3. The Lancet Haematology (31)
  4. Journal of Molecular Diagnostics (23)
  5. Value in Health (20)
  6. Lancet (13)

More Publications

Results (257)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): A single-arm, open-label, phase 1, dose-escalation study
    Journal Article

    Iyer, S. P.; Sica, R. A.; Ho, P. J.; Prica, A.; Zain, J.; Foss, F. M.; Hu, B.; Beitinjaneh, A.; Weng, W. K.; Kim, Y. H.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: A phase 1, first-in-human trial
    Journal Article

    Ghobadi, A.; Bachanova, V.; Patel, K.; Park, J. H.; Flinn, I.; Riedell, P. A.; Bachier, C.; Diefenbach, C. S.; Wong, C.; Bickers, C.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): A multicentre, open-label, single-arm, phase 2 study
    Journal Article

    Zinzani, P. L.; Izutsu, K.; Mehta-Shah, N.; Barta, S. K.; Ishitsuka, K.; Córdoba, R.; Kusumoto, S.; Bachy, E.; Cwynarski, K.; Gritti, G.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human, multicentre, open-label, single-arm, phase 1 study
    Journal Article

    Maruyama, D.; Jacobsen, E.; Porcu, P.; Allen, P.; Ishitsuka, K.; Kusumoto, S.; Narita, T.; Tobinai, K.; Foss, F.; Tsukasaki, K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
    Review

    Aldoss, I.; Roboz, G. J.; Bassan, R.; Boissel, N.; DeAngelo, D. J.; Fleming, S.; Gökbuget, N.; Logan, A. C.; Luger, S. M.; Menne, T.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • N/KRAS-mutant AML LSCS originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax
    Meeting Abstract

    Sango, J.; Carcamo, S.; Sirenko, M.; Maiti, A.; Mansour, H.; Ulukaya, G.; Tomalin, L.; Olivier, E.; Olszewska, M.; Demircioglu, D.; more...
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Production of alarmins S100a8/A9 by DNMT3A-mutant hematopoietic cells causes mesenchymal stromal cell senescence and seeds a pro-inflammatory environment in clonal hematopoiesis
    Meeting Abstract

    Mistry, J.; Young, K.; Maestre, I. F.; Levine, R.; Trowbridge, J.
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Regulation of the hematopoietic stem cell pool by C-Kit-associated trogocytosis
    Meeting Abstract

    Gao, X.; Carpenter, R.; Boulais, P.; Zhang, D.; Marlein, C.; Li, H.; Smith, M.; Chung, D.; Maryanovich, M.; Will, B.; more...
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma
    Review

    Abramson, J. S.; Stuver, R.; Herrera, A.; Patterson, E.; Wen, Y. P.; Moskowitz, A.
    Critical Reviews in Oncology/Hematology (2024)

    Fulltext@MSK | Save